Future Fertility, a Toronto, Canada-based fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical decision-making infertility care, and in vitro fertilization (IVF), raised a Series A financing round of undisclosed amount.
The round was led by M Ventures, with participation from Whitecap Venture Partners.
The fund will enable Future Fertility to further develop its ground-breaking technology and to help improve the outcomes of IVF for millions of patients.
Company: Future Fertility Inc.
Raised: undisclosed amount
Round: Series A
Funding Month: January 2022
Lead Investors: M Ventures
Additional Investors: Whitecap Venture Partners
Company Website: https://futurefertility.com/
Software Category: AI-enabled and non-invasive fertility solutions
About the Company: Led by Diana Olusanmi, Chief Executive Officer, and Dr. Dan Nayot, Future Fertility aims to harness the power of AI to improve fertility care and IVF outcomes, lower its costs, and alleviate the emotional stress of the patient journey. Future Fertility is developing first-in-class non-invasive software solutions to help clinicians and embryologists to personalize care and as a result, improve fertility care outcomes. Future Fertility’s first non-invasive AI solution can detect features of a woman’s egg that are invisible to the human eye and can predict the likelihood of fertilization and embryo (blastocyst) development. The product is already used in a number of innovative clinics around the world and has been consistently shown to be significantly more accurate at predicting egg quality compared to current methods. The company’s mission is to harness the power of AI to improve fertility care and IVF outcomes, lower its costs and alleviate the emotional stress of the patient journey.